Psychiatry - December 2008 - (Page 40)

33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. Psychiatry. 1983;18:237–241. Nolan B. Acute suicidal depression associated with use of timolol (case report). JAMA. 1982;247:1567. Kurtz S, Ashkenazi I, Melamed S. Major depressive episode secondary to antiglaucoma drugs. Am J Psychiatry. 1993;150:523–525. Russel J, Schuckit MA. Anxiety and depression in patient on nadolol. Lancet. 1982;2(8310):1286–1287. Hansteen V, Moinichen E, Lorensten E, et al. One year’s treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. BMJ. 1982;284:155–160. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA. 1982;247:1707–1714. Perez-Stable E, Gardiener PS, Baron RB, et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am J Med. 2000;108:359–365. Julian D, Prescott RJ, Jackson FS, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. 1982;1:1142–1147. Packer M, Bristow MR, Chon JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355. Ko DT, Hebert PR, Coffey CS, et al. B-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002:288(3);351–357. Hullet FJ, Potkin SG, Levy AB, Ciasca R. Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry. 1988;145(10):1277–1279. Patalia AH, Rathod NR, Gandhi RR, et al. Depression—an adverse event with nifedipine. J Assoc Physicians India. 2002;50:1432–1434. Biriell C, McEwen J, Sanz E. Depression associated with Psychiatry 2008 [ V O L U M E 5, NUMBER 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. diltiazem. BMJ. 1989;299:796. Dassylva B. Verapamil may cause depression. Can J Psychiatry. 1993:38:299–300. Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7(5):478–484. Lindberg G, Bingefors K, Ranstam J, et al. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. BMJ. 1998;316:741–745. Dunn NR, Freemantle SN, Mann RD. Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression. Br J Clin Pharmacol. 1999;48(2):230–233. Hertzman m, Adler LW, Arling B, Kern M. Lisinopril may augment antidepressant response. J Clin Psychopharmacol. 2005;25:681–620. Germain L, Chouinard G. Captopril treatment of major depression with serial measurements of blood cortisol concentrations. Biol Psychiatry. 1989;25:489–493. Germain L, Chouinard G. Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry. 1988;23:637–641. Ullrich H, Passenberg P, Agelink MW. Episodes of depression with attempted suicide after taking valsartan with hydrochlorthiazide. Dtsch Med Wochenschr. 2003;128:2534–2536. Gard PR, Mandy A, Sutcliffe MA. Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression. Biol Psychiatry. 1999;45(8):1030–1034. Christensen R, Kristensen PK, Bartels H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomized trials. Lancet. 2007;370:1706-1713. US Food and Drug Administration. Endocrinologic and Metabolic Drugs Advisory Committee. June 13, 2007. Briefing information. DECEMBER] 56. 57. 58. 59. 60. 61. 62. 63. 64. NDA 21-888. Zimulti® (rimonabant). http://www.fda.gov/ohrms/dockets/ ac/07/briefing/2007-4306b1-00index.htm. Accessed date: August 31, 2008. Loftus P. Merck ends development of obesity drug. October 3, 2008. The Wall Street Journal. http://online.wsj.com/article/SB122 297743887899291.html?mod=rss_w hats_news_us_business. Accessed October 3, 2008. Bonaccorso S, Marino V, Biondi M, et al. Depression induced by treatment with interferon=alpha in patients affected by hepatitis C virus. J Affect Disord. 2002;72:237–241. Castera L, Zigante F, Bastie A, et al. Incidence of interferon alfainduced depression in patients with chronic hepatitis C. Hepatology 2002;35:978–979. Hosoda S, Takimura H, Shibayama M, et al. Psychiatric symptoms related to interferon therapy for chronic hepatitis C. Clonical features and prognosis. Psychiatry Clin Neurosc. 2000;54:565–572. Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon induced major depressive disorder in patients with hepatitis C. Mol Psychiatry. 2002;77:942–947. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25:283–291. Jacobs LD, Beck RY, Simon JH, et al. Intramuscular interferon beta1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898–904. Patten SB, Metz LM. Interferon beta-1a and depression in relapsing-remitting multiple sclerosis: An analysis of depression data from the PRISMS clinical trial. Mult Scler. 2001;7:243–48. Patten SB, Metz LM. Interferon beta-1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial. 40 12, http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-00-index.htm http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-00-index.htm http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4306b1-00-index.htm http://online.wsj.com/article/SB122297743887899291.html?mod=rss_whats_news_us_business http://online.wsj.com/article/SB122297743887899291.html?mod=rss_whats_news_us_business http://online.wsj.com/article/SB122297743887899291.html?mod=rss_whats_news_us_business

Table of Contents Feed for the Digital Edition of Psychiatry - December 2008

Psychiatry - December 2008 Editor’s Message Contents Editorial Advisory Board Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysmorphic Disorder Pain, Pain, Go Away: Antidepressants and Pain Management Why Psychotherapy Helps the Patient in Chronic Pain General Medical Drugs Associated with Depression Katatonia: A New Conceptual Understanding of Catatonia and a New Rating Scale Thermoregulation and the Role of Calcium Signalling in Neurotransmission Cognition and Schizophrenia: Is There a Role for Cognitive Assessments in Diagnosis and Treatment? Journal Watch Information for Authors

Psychiatry - December 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.